Premier Research Expands its Medical Device Operations to the United States
PHILADELPHIA, March 11 /PRNewswire/-Premier Research Group Limited, the international clinical services group, is pleased to announce that it has expanded their medical device operations to include full coverage in the United States. Their dedicated medical device group has been offering clinical trials services in Europe since 1997 and is considered an industry leader for managing medical device trials and support services.
"Our clients have requested expanded medical device services, and we are committed to responding to these needs," explained Premier Research Group COO Dr. Troy McCall. "Providing both US and EU medical devices services is a strategic focus for our company and this will strengthen our ability to respond to customer's needs as well as offer a broader range of services for the global market."
U.S. medical device operations will be overseen by Efraim Roe Kozorovitsky, Executive Director, Medical Devices, and a 4-year veteran of the company. Mr. Roe has relocated from Switzerland to the United States. "Since July 2008, we have been establishing the infrastructure for our capabilities in the U.S. and today we are pleased to announce that we have the expertise in place to deliver the same quality that we have been providing in Europe for the past ten years. I look forward to growing this group," he commented.
About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.
Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
